Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up

<h3>Background</h3><p>Baló concentric sclerosis (BCS) is a rare demyelinating disorder that overlaps with other demyelinating diseases. BCS usually present in the context of multiple sclerosis (MS) or preceding typical MS. It rarely presents as an isolated lesion, . IV methyl predn...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Lina Okar (14777164) (author)
مؤلفون آخرون: Beatriz Canibano (8957343) (author), Dirk Deleu (4919410) (author)
منشور في: 2023
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513550814281728
author Lina Okar (14777164)
author2 Beatriz Canibano (8957343)
Dirk Deleu (4919410)
author2_role author
author
author_facet Lina Okar (14777164)
Beatriz Canibano (8957343)
Dirk Deleu (4919410)
author_role author
dc.creator.none.fl_str_mv Lina Okar (14777164)
Beatriz Canibano (8957343)
Dirk Deleu (4919410)
dc.date.none.fl_str_mv 2023-12-01T00:00:00Z
dc.identifier.none.fl_str_mv 10.1016/j.nerep.2023.100177
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Management_of_Bal_Concentric_Sclerosis_with_rituximab_A_case_study_with_long-term_follow-up/23918439
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Immunology
Neurosciences
Pharmacology and pharmaceutical sciences
demyelinating disorder
Baló concentric sclerosis
multiple sclerosis
rituximab
dc.title.none.fl_str_mv Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Background</h3><p>Baló concentric sclerosis (BCS) is a rare demyelinating disorder that overlaps with other demyelinating diseases. BCS usually present in the context of multiple sclerosis (MS) or preceding typical MS. It rarely presents as an isolated lesion, . IV methyl prednisolone (IVMP) is the mainstay in the treatment with various outcomes. Maintenance therapy is still not clearly defined. Case presentation/case report: We present a case of isolated BCS that responded clinically and radiologically to long-term rituximab therapy.</p><h3>Conclusion</h3><p>A definite guideline for treating patient with BCS either with MS or as isolated entity is still controversial. Our case reflects a remarkable response to rituximab in achieving clinical and radiological longterm remission.</p><h2>Other Information</h2><p>Published in: Neuroimmunology Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" rel="noreferrer" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.nerep.2023.100177" target="_blank">https://dx.doi.org/10.1016/j.nerep.2023.100177</a></p>
eu_rights_str_mv openAccess
id Manara2_c66166e9105dfc41b997e62698a23e29
identifier_str_mv 10.1016/j.nerep.2023.100177
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/23918439
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-upLina Okar (14777164)Beatriz Canibano (8957343)Dirk Deleu (4919410)Biomedical and clinical sciencesImmunologyNeurosciencesPharmacology and pharmaceutical sciencesdemyelinating disorderBaló concentric sclerosismultiple sclerosisrituximab<h3>Background</h3><p>Baló concentric sclerosis (BCS) is a rare demyelinating disorder that overlaps with other demyelinating diseases. BCS usually present in the context of multiple sclerosis (MS) or preceding typical MS. It rarely presents as an isolated lesion, . IV methyl prednisolone (IVMP) is the mainstay in the treatment with various outcomes. Maintenance therapy is still not clearly defined. Case presentation/case report: We present a case of isolated BCS that responded clinically and radiologically to long-term rituximab therapy.</p><h3>Conclusion</h3><p>A definite guideline for treating patient with BCS either with MS or as isolated entity is still controversial. Our case reflects a remarkable response to rituximab in achieving clinical and radiological longterm remission.</p><h2>Other Information</h2><p>Published in: Neuroimmunology Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" rel="noreferrer" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.nerep.2023.100177" target="_blank">https://dx.doi.org/10.1016/j.nerep.2023.100177</a></p>2023-12-01T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.nerep.2023.100177https://figshare.com/articles/journal_contribution/Management_of_Bal_Concentric_Sclerosis_with_rituximab_A_case_study_with_long-term_follow-up/23918439CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/239184392023-12-01T00:00:00Z
spellingShingle Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
Lina Okar (14777164)
Biomedical and clinical sciences
Immunology
Neurosciences
Pharmacology and pharmaceutical sciences
demyelinating disorder
Baló concentric sclerosis
multiple sclerosis
rituximab
status_str publishedVersion
title Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
title_full Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
title_fullStr Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
title_full_unstemmed Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
title_short Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
title_sort Management of Baló Concentric Sclerosis with rituximab: A case study with long-term follow-up
topic Biomedical and clinical sciences
Immunology
Neurosciences
Pharmacology and pharmaceutical sciences
demyelinating disorder
Baló concentric sclerosis
multiple sclerosis
rituximab